H. Irene Su

H. Irene Su has characterized the reproductive endocrine outcomes of cancer treatment, developing biomarker-based models to predict premature menopause and reproductive lifespan in cancer survivors. Her work on reproductive aging after cancer treatment has shown that chemotherapy accelerates ovarian aging beyond what is explained by follicle loss alone, involving vascular and stromal damage. Her research on contraception in oncology has established evidence-based guidelines for safe contraceptive choices during and after cancer treatment.